The Sick Times
  • Sections
    • Arts & Culture
    • Commentary
    • COVID-19
    • Health
    • International
    • Podcast
    • Policy & Advocacy
    • Science
  • About
    • Our team
    • Write for us
    • Transparency & policies
  • Resources
Newsletter
Donate
  • Department of Defense funds $8 million grant for Long COVID trials

    Department of Defense funds $8 million grant for Long COVID trials

    Betsy Ladyzhets

    A new U.S. clinical trials program called PROBE-PASC was announced on Friday at a Long COVID conference in Amsterdam. The program received initial funding of $8 million from a Department of Defense (DOD) grant. Read more…

Recent articles

  • National COVID-19 trends, September 1
    COVID-19
    Betsy Ladyzhets

    National COVID-19 trends, September 1

  • Research updates, September 1
    Science
    Miles W. Griffis

    Research updates, September 1

  • “We’re going to stop the gaslighting right now”: How I’m fighting back as a Black woman with Long COVID
    Commentary
    Kelly Sealey

    “We’re going to stop the gaslighting right now”: How I’m fighting back as a Black woman with Long COVID

Get the latest Long COVID news and commentary

Sign up for our free newsletter, delivered every Tuesday! Receive our latest stories, research updates, COVID-19 trends, and more.

Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.

Check out our weekly podcast, Still Here

SpotifySpotifyApple PodcastsApple PodcastsPocketCastsPocketCastsiHeartRadioiHeartRadioRSSRSS

Trending

Department of Defense funds $8 million grant for Long COVID trialsDepartment of Defense funds $8 million grant for Long COVID trialsBetsy Ladyzhets
“We’re going to stop the gaslighting right now”: How I’m fighting back as a Black woman with Long COVID“We’re going to stop the gaslighting right now”: How I’m fighting back as a Black woman with Long COVIDKelly Sealey
National COVID-19 trends, August 25National COVID-19 trends, August 25Betsy Ladyzhets
FDA approves COVID-19 antiviral Xocova as PEP. But will it be accessible?FDA approves COVID-19 antiviral Xocova as PEP. But will it be accessible?Miles W. Griffis
Research updates, August 25Research updates, August 25Miles W. Griffis

Policy & Advocacy

Science

  • September 23, 2024

    Live blog: Following the RECOVER-Treating Long COVID kickoff event

  • blood sugar meter and medication on the blue background
    September 17, 2024

    Research updates, September 17

  • white and yellow lego blocks
    September 10, 2024

    Research updates, September 10

  • red bloodcells on white surface
    September 3, 2024

    Research updates, September 3

  • crop man putting medical mask on face of ethnic child
    August 27, 2024

    Research updates, August 27

  • a doctor doing an ear examination
    August 20, 2024

    Research updates, August 20

Previous Page
1 … 26 27 28 29 30 … 38
Next Page

Covid-19

  • February 20, 2024

    The CDC’s proposed isolation guidance is (still) not based on data or science

  • February 20, 2024

    National Covid-19 trends, February 20

  • February 13, 2024

    National Covid-19 trends, February 13

  • photo of abstract painting
    February 6, 2024

    How we track Covid-19, with wastewater and other data sources

  • February 6, 2024

    National Covid-19 trends, February 6

  • January 30, 2024

    National Covid-19 trends, January 30

Previous Page
1 … 26 27 28 29 30 31
Next Page

Health

Commentary

  • November 14, 2023

    Welcome to The Sick Times, a letter from our co-founder, Betsy Ladyzhets

  • woman in beige coat standing near white wooden book shelf
    November 14, 2023

    We want to hear from you! Take our reader survey

Previous Page
1 … 25 26 27

The Sick Times is an independent news site founded by journalists Betsy Ladyzhets and Miles Griffis. We report on the Long COVID crisis, COVID-19, and infection-associated illnesses.

Contact:
editors@thesicktimes.org

PO Box 331009
Brooklyn, NY 11233

  1. Home
  2. About
  3. Newsletter
  4. Podcast
  5. Transparency & policies
  6. Write for us
  7. Resources
  8. Donate
  • Twitter
  • Instagram
  • YouTube
  • Facebook
  • Bluesky

Sign up for our free newsletter, delivered every Tuesday. Receive our latest stories, research updates, COVID-19 trends, and more.

Processing…
Success! You're on the list 🙂
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.

© 2026 The Sick Times

Loading Comments...